Australia markets closed

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.80-0.54 (-1.34%)
At close: 04:00PM EDT
39.80 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-188,597
-182,393
-125,373
-78,882
-28,837
Depreciation & amortisation
3,786
3,541
1,624
906
644
Deferred income taxes
-177
-292
-44
58
-285
Stock-based compensation
35,778
32,372
20,376
10,017
5,677
Change in working capital
-2,581
5,635
-676
-2,647
-26,089
Accounts receivable
-58
130
1,757
-459
-1,032
Other working capital
-157,693
-150,944
-101,324
-71,552
-50,761
Other non-cash items
-
-
-
-
216
Net cash provided by operating activities
-154,094
-145,327
-98,430
-69,502
-48,124
Cash flows from investing activities
Investments in property, plant and equipment
-3,599
-5,617
-2,894
-2,050
-2,637
Purchases of investments
-862,473
-793,907
-551,137
-389,474
-228,897
Sales/maturities of investments
656,078
682,354
258,028
144,754
214,710
Net cash used for investing activities
-209,994
-117,170
-296,003
-246,770
-16,824
Cash flows from financing activities
Debt repayment
-
-
0
0
-16,743
Common stock issued
-
353,487
277,766
447,283
102,456
Net cash used provided by (used for) financing activities
-
353,522
278,471
447,543
85,795
Net change in cash
-10,616
91,401
-118,446
130,679
20,254
Cash at beginning of period
69,512
57,242
175,688
45,009
24,755
Cash at end of period
58,946
148,643
57,242
175,688
45,009
Free cash flow
Operating cash flow
-154,094
-145,327
-98,430
-69,502
-48,124
Capital expenditure
-3,599
-5,617
-2,894
-2,050
-2,637
Free cash flow
-157,693
-150,944
-101,324
-71,552
-50,761